On Tuesday, Shares of Incyte Corporation (NASDAQ:INCY), dropped -1.76% to $99.60.
Incyte Corporation, declared it will present at the following investor conferences during the month of May:
- Deutsche Bank Securities 40th Annual Health Care Conference on Thursday, May 7, 2015 at 10:00 am (EDT) in Boston;
- Bank of America Merrill Lynch 2015 Health Care Conference on Thursday, May 14, 2015 at 8:00 am (PDT) in Las Vegas; and
- UBS Global Healthcare Conference on Tuesday, May 19, 2015 at 3:00 pm (EDT) in New York.
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. It offers JAKAFI, an oral janus associated kinase (JAK) inhibitor for the treatment of patients with intermediate or high-risk myelofibrosis (MF), counting primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF.
Shares of Alkermes plc (NASDAQ:ALKS), declined -1.70% to $57.16, during its last trading session.
Alkermes, will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Thursday, April 30, 2015, to talk about the company’s first quarter 2015 financial results. Administration will also provide an update on the company.
The conference call will be webcast on the Investors section of Alkermes’ website at www.alkermes.com or may be accessed by dialing +1 888 424 8151 for U.S. callers and +1 847 585 4422 for international callers. The conference call ID number is 6037988.
Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas.
At the end of Tuesday’s trade, Shares of Energy Transfer Partners, L.P. (NYSE:ETP), dwindled -1.65% to $54.40.
Energy Transfer Partners, declared that its Board of Directors has approved a $0.04 enhance in its quarterly cash distribution to $0.49 per ETE common unit for the first quarter ended March 31, 2015, or $1.96 per unit on an annualized basis.
The quarterly distribution of $0.49 per ETE common unit represents a distribution enhance of 37% on an annualized basis contrast to the first quarter of 2014. This also represents an annualized distribution enhance of $0.16 per common unit, or 8.9%, contrast to the fourth quarter of 2014 and marks the tenth successive quarter that ETE has raised its distribution. The cash distribution will be paid on May 19, 2015 to unitholders of record as of the close of business on May 8, 2015.
ETE plans to release earnings for the first quarter of 2015 on Wednesday, May 6, 2015, after the market closes. ETE and its partner, Energy Transfer Partners, L.P. (ETP), will conduct a joint conference call on Thursday, May 7, 2015 at 8:00 a.m. Central Time to talk about quarterly results.
Energy Transfer Partners, L.P. engages in the natural gas midstream, and intrastate transportation and storage businesses in the United States. The company’s Intrastate Transportation and Storage segment transports natural gas from various natural gas producing areas, in addition to through its ET fuel system and HPL system.
Finally, Regency Energy Partners LP (NYSE:RGP), ended its last trade with -1.63% loss, and closed at $22.35.
ETE owns the general partner and 100% of the IDRs of Regency Energy Partners LP (RGP) and about 57.2 million RGP common units.
Regency Energy Partners LP engages in the gathering and processing, compression, treating, and transportation of natural gas; and transportation, fractionation, and storage of natural gas liquids (NGLs). It operates in Gathering and Processing, Natural Gas Transportation, NGL Services, Contract Services, and Natural Resources segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
